Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1996 Oct;61(4):347–351. doi: 10.1136/jnnp.61.4.347

Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.

A S Whitehead 1, S Bertrandy 1, F Finnan 1, A Butler 1, G D Smith 1, Y Ben-Shlomo 1
PMCID: PMC486573  PMID: 8890771

Abstract

OBJECTIVES: It has been suggested that Parkinson's disease and Alzheimer's disease may share a common or at least overlapping aetiology. The prevalence of dementia among cases of Parkinson's disease is known to be greater than expected in the general population. The frequency of the apolipoprotein epsilon 4 allele in a large case-control study of early onset Parkinson's disease has been examined. METHODS: 215 patients and 212 population based controls were recruited from the Republic of Ireland between 1992 and 1994. Cases had to have disease onset at 55 years or younger and be born after 1925. RESULTS: The frequency of the epsilon 4 allele was almost identical between cases of Parkinson's disease (14.6%) and healthy controls (13.3%). There was no relation between epsilon 4 status and disease onset, disease duration, Hoehn and Yahr score, and disease progression. The frequency of the epsilon 4 allele was not increased among 10 patients with Parkinson's disease with dementia (10.0%) compared with the other patients without dementia (14.8%). There was no association between epsilon 4 allele status and either a history of smoking, family history of dementia, or Parkinson's disease, or being born in a rural area. The odds ratio for the ApoE epsilon 4 allele associated with Parkinson's disease was 1.10 (95% confidence interval (95% CI) 0.68-1.79), adjusting for age group, sex, and residential status. The pooled odds ratio from a meta-analysis of six studies of ApoE epsilon 4 status and Parkinson's disease was 0.94 (95% CI 0.69-1.27). CONCLUSIONS: The results from our study as well as the pooled meta-analysis exclude any important role for ApoE epsilon 4 status in the development of Parkinson's disease. Our results similarly do not support its role either in dementia associated with Parkinson's disease or disease prognosis.

Full text

PDF
350

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agid Y. Parkinson's disease: pathophysiology. Lancet. 1991 Jun 1;337(8753):1321–1324. doi: 10.1016/0140-6736(91)92989-f. [DOI] [PubMed] [Google Scholar]
  2. Arai H., Higuchi S., Muramatsu T., Iwatsubo T., Sasaki H., Trojanowski J. Q. Apolipoprotein E gene in diffuse Lewy body disease with or without co-existing Alzheimer's disease. Lancet. 1994 Nov 5;344(8932):1307–1307. doi: 10.1016/s0140-6736(94)90799-4. [DOI] [PubMed] [Google Scholar]
  3. Arai H., Muramatsu T., Higuchi S., Sasaki H., Trojanowski J. Q. Apolipoprotein E gene in Parkinson's disease with or without dementia. Lancet. 1994 Sep 24;344(8926):889–889. doi: 10.1016/s0140-6736(94)92862-2. [DOI] [PubMed] [Google Scholar]
  4. Baron J. A. Cigarette smoking and Parkinson's disease. Neurology. 1986 Nov;36(11):1490–1496. doi: 10.1212/wnl.36.11.1490. [DOI] [PubMed] [Google Scholar]
  5. Ben-Shlomo Y., Marmot M. G. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? J Neurol Neurosurg Psychiatry. 1995 Mar;58(3):293–299. doi: 10.1136/jnnp.58.3.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ben-Shlomo Y., Sieradzan K. Idiopathic Parkinson's disease: epidemiology, diagnosis and management. Br J Gen Pract. 1995 May;45(394):261–268. [PMC free article] [PubMed] [Google Scholar]
  7. Ben-Shlomo Y., Whitehead A. S., Smith G. D. Parkinson's, Alzheimer's, and motor neurone disease. BMJ. 1996 Mar 23;312(7033):724–724. doi: 10.1136/bmj.312.7033.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Benjamin R., Leake A., Edwardson J. A., McKeith I. G., Ince P. G., Perry R. H., Morris C. M. Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet. 1994 Jun 18;343(8912):1565–1565. doi: 10.1016/s0140-6736(94)92961-0. [DOI] [PubMed] [Google Scholar]
  9. Boyles J. K., Pitas R. E., Wilson E., Mahley R. W., Taylor J. M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest. 1985 Oct;76(4):1501–1513. doi: 10.1172/JCI112130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Boyles J. K., Zoellner C. D., Anderson L. J., Kosik L. M., Pitas R. E., Weisgraber K. H., Hui D. Y., Mahley R. W., Gebicke-Haerter P. J., Ignatius M. J. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest. 1989 Mar;83(3):1015–1031. doi: 10.1172/JCI113943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Brown R. G., Marsden C. D. How common is dementia in Parkinson's disease? Lancet. 1984 Dec 1;2(8414):1262–1265. doi: 10.1016/s0140-6736(84)92807-1. [DOI] [PubMed] [Google Scholar]
  12. Calne D. B., Eisen A., McGeer E., Spencer P. Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment? Lancet. 1986 Nov 8;2(8515):1067–1070. doi: 10.1016/s0140-6736(86)90469-1. [DOI] [PubMed] [Google Scholar]
  13. Cumming A. M., Robertson F. W. Polymorphism at the apoprotein-E locus in relation to risk of coronary disease. Clin Genet. 1984 Apr;25(4):310–313. doi: 10.1111/j.1399-0004.1984.tb01995.x. [DOI] [PubMed] [Google Scholar]
  14. Duvoisin R. C. The genetics of Parkinson's disease. A review. Adv Neurol. 1993;60:306–315. [PubMed] [Google Scholar]
  15. Elshourbagy N. A., Liao W. S., Mahley R. W., Taylor J. M. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci U S A. 1985 Jan;82(1):203–207. doi: 10.1073/pnas.82.1.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  17. Forno L. S. The Lewy body in Parkinson's disease. Adv Neurol. 1987;45:35–43. [PubMed] [Google Scholar]
  18. Galasko D., Saitoh T., Xia Y., Thal L. J., Katzman R., Hill L. R., Hansen L. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology. 1994 Oct;44(10):1950–1951. doi: 10.1212/wnl.44.10.1950. [DOI] [PubMed] [Google Scholar]
  19. Gearing M., Schneider J. A., Rebeck G. W., Hyman B. T., Mirra S. S. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology. 1995 Nov;45(11):1985–1990. doi: 10.1212/wnl.45.11.1985. [DOI] [PubMed] [Google Scholar]
  20. Hardy J., Crook R., Prihar G., Roberts G., Raghavan R., Perry R. Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease. Neurosci Lett. 1994 Nov 21;182(1):1–2. doi: 10.1016/0304-3940(94)90190-2. [DOI] [PubMed] [Google Scholar]
  21. Harrington C. R., Louwagie J., Rossau R., Vanmechelen E., Perry R. H., Perry E. K., Xuereb J. H., Roth M., Wischik C. M. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol. 1994 Dec;145(6):1472–1484. [PMC free article] [PubMed] [Google Scholar]
  22. Harrington C. R., Perry R. H., Perry E. K., Hurt J., McKeith I. G., Roth M., Wischik C. M. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia. 1994 Sep-Oct;5(5):215–228. doi: 10.1159/000106727. [DOI] [PubMed] [Google Scholar]
  23. Hixson J. E., Vernier D. T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990 Mar;31(3):545–548. [PubMed] [Google Scholar]
  24. Hoehn M. M., Yahr M. D. Parkinsonism: onset, progression and mortality. Neurology. 1967 May;17(5):427–442. doi: 10.1212/wnl.17.5.427. [DOI] [PubMed] [Google Scholar]
  25. Hofman A., Schulte W., Tanja T. A., van Duijn C. M., Haaxma R., Lameris A. J., Otten V. M., Saan R. J. History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease. Neurology. 1989 Dec;39(12):1589–1592. doi: 10.1212/wnl.39.12.1589. [DOI] [PubMed] [Google Scholar]
  26. Hughes A. J., Daniel S. E., Kilford L., Lees A. J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181–184. doi: 10.1136/jnnp.55.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jellinger K. Neuropathological substrates of Alzheimer's disease and Parkinson's disease. J Neural Transm Suppl. 1987;24:109–129. [PubMed] [Google Scholar]
  28. Jenner P., Schapira A. H., Marsden C. D. New insights into the cause of Parkinson's disease. Neurology. 1992 Dec;42(12):2241–2250. doi: 10.1212/wnl.42.12.2241. [DOI] [PubMed] [Google Scholar]
  29. Jiménez-Jiménez F. J., Mateo D., Giménez-Roldán S. Exposure to well water and pesticides in Parkinson's disease: a case-control study in the Madrid area. Mov Disord. 1992;7(2):149–152. doi: 10.1002/mds.870070209. [DOI] [PubMed] [Google Scholar]
  30. Koller W. C., Glatt S. L., Hubble J. P., Paolo A., Tröster A. I., Handler M. S., Horvat R. T., Martin C., Schmidt K., Karst A. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol. 1995 Feb;37(2):242–245. doi: 10.1002/ana.410370215. [DOI] [PubMed] [Google Scholar]
  31. Koller W., Vetere-Overfield B., Gray C., Alexander C., Chin T., Dolezal J., Hassanein R., Tanner C. Environmental risk factors in Parkinson's disease. Neurology. 1990 Aug;40(8):1218–1221. doi: 10.1212/wnl.40.8.1218. [DOI] [PubMed] [Google Scholar]
  32. Kuusisto J., Koivisto K., Kervinen K., Mykkänen L., Helkala E. L., Vanhanen M., Hänninen T., Pyörälä K., Kesäniemi Y. A., Riekkinen P. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ. 1994 Sep 10;309(6955):636–638. doi: 10.1136/bmj.309.6955.636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mahley R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988 Apr 29;240(4852):622–630. doi: 10.1126/science.3283935. [DOI] [PubMed] [Google Scholar]
  34. Majoor-Krakauer D., Ottman R., Johnson W. G., Rowland L. P. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility. Neurology. 1994 Oct;44(10):1872–1877. doi: 10.1212/wnl.44.10.1872. [DOI] [PubMed] [Google Scholar]
  35. Marder K., Maestre G., Cote L., Mejia H., Alfaro B., Halim A., Tang M., Tycko B., Mayeux R. The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology. 1994 Jul;44(7):1330–1331. doi: 10.1212/wnl.44.7.1330. [DOI] [PubMed] [Google Scholar]
  36. Mutch W. J., Dingwall-Fordyce I., Downie A. W., Paterson J. G., Roy S. K. Parkinson's disease in a Scottish city. Br Med J (Clin Res Ed) 1986 Feb 22;292(6519):534–536. doi: 10.1136/bmj.292.6519.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Pickering-Brown S. M., Mann D. M., Bourke J. P., Roberts D. A., Balderson D., Burns A., Byrne J., Owen F. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases. Lancet. 1994 May 7;343(8906):1155–1155. doi: 10.1016/s0140-6736(94)90257-7. [DOI] [PubMed] [Google Scholar]
  38. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993 Sep 18;342(8873):697–699. doi: 10.1016/0140-6736(93)91705-q. [DOI] [PubMed] [Google Scholar]
  39. Poirier J., Hess M., May P. C., Finch C. E. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res Mol Brain Res. 1991 Sep;11(2):97–106. doi: 10.1016/0169-328x(91)90111-a. [DOI] [PubMed] [Google Scholar]
  40. Riggs J. E. Smoking and Alzheimer's disease: protective effect or differential survival bias? Lancet. 1993 Sep 25;342(8874):793–794. doi: 10.1016/0140-6736(93)91547-y. [DOI] [PubMed] [Google Scholar]
  41. Rubinsztein D. C., Hanlon C. S., Irving R. M., Goodburn S., Evans D. G., Kellar-Wood H., Xuereb J. H., Bandmann O., Harding A. E. Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. Mol Cell Probes. 1994 Dec;8(6):519–525. doi: 10.1006/mcpr.1994.1073. [DOI] [PubMed] [Google Scholar]
  42. St Clair D., Norrman J., Perry R., Yates C., Wilcock G., Brookes A. Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. Neurosci Lett. 1994 Jul 18;176(1):45–46. doi: 10.1016/0304-3940(94)90867-2. [DOI] [PubMed] [Google Scholar]
  43. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977–1981. doi: 10.1073/pnas.90.5.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]
  45. van Duijn C. M., Havekes L. M., Van Broeckhoven C., de Knijff P., Hofman A. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ. 1995 Mar 11;310(6980):627–631. doi: 10.1136/bmj.310.6980.627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. van Duijn C. M., de Knijff P., Cruts M., Wehnert A., Havekes L. M., Hofman A., Van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994 May;7(1):74–78. doi: 10.1038/ng0594-74. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES